164 related articles for article (PubMed ID: 1386567)
1. Addition of enoximone to adrenergic agents in the management of severe heart failure.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Crit Care Med; 1992 Aug; 20(8):1102-6. PubMed ID: 1386567
[TBL] [Abstract][Full Text] [Related]
2. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
[TBL] [Abstract][Full Text] [Related]
3. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
4. Enoximone improves selection of candidates for urgent cardiac transplantation.
Loisance D; Benvenuti C; Dubois Randé JL; Deleuze P; Castaigne A; Cachera JP
Int J Cardiol; 1990 Jul; 28 Suppl 1():S23-7. PubMed ID: 2145234
[TBL] [Abstract][Full Text] [Related]
5. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
[TBL] [Abstract][Full Text] [Related]
7. Intravenous use of enoximone.
Crawford MH
Am J Cardiol; 1987 Aug; 60(5):42C-45C. PubMed ID: 2956867
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
[TBL] [Abstract][Full Text] [Related]
9. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
[TBL] [Abstract][Full Text] [Related]
11. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M
Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
[TBL] [Abstract][Full Text] [Related]
12. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
[TBL] [Abstract][Full Text] [Related]
13. A dose-response study of intravenous enoximone in congestive heart failure.
Erbel R; Meyer J; Diefenbach C; Delorme G; Bourdarias JP; Vernant P; Lellouche D; Mattioli G; Barbieri A; Installe E
Am J Cardiol; 1987 Aug; 60(5):31C-36C. PubMed ID: 2956865
[TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
Gilbert EM; Bristow MR; Mason JW
Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
[TBL] [Abstract][Full Text] [Related]
15. Effects of low dose enoximone for chronic congestive heart failure.
Jessup M; Ulrich S; Samaha J; Helfer D
Am J Cardiol; 1987 Aug; 60(5):80C-84C. PubMed ID: 2956875
[TBL] [Abstract][Full Text] [Related]
16. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
[TBL] [Abstract][Full Text] [Related]
17. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of enoximone and nitroprusside in unstable chronic heart failure.
Treese N; Erbel R; Rhein S; Henrichs KJ; Meyer J
Eur Heart J; 1989 Jun; 10(6):484-92. PubMed ID: 2527155
[TBL] [Abstract][Full Text] [Related]
19. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dobutamine and enoximone for low output states following cardiac surgery.
Orellano L; Darwisch M; Dieterich HA; Köllner V
Int J Cardiol; 1990 Jul; 28 Suppl 1():S13-9. PubMed ID: 2145233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
